BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 37239077)

  • 61. Current approaches to the treatment of paraneoplastic encephalitis.
    Grisold W; Giometto B; Vitaliani R; Oberndorfer S
    Ther Adv Neurol Disord; 2011 Jul; 4(4):237-48. PubMed ID: 21765874
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Paraneoplastic neurological syndromes and autoimmune encephalitis].
    Stich O; Rauer S
    Nervenarzt; 2014 Apr; 85(4):485-98; quiz 499-501. PubMed ID: 24668402
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurological paraneoplastic syndromes: an update.
    Berzero G; Psimaras D
    Curr Opin Oncol; 2018 Nov; 30(6):359-367. PubMed ID: 30124520
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Managing paraneoplastic neurological disorders.
    de Beukelaar JW; Sillevis Smitt PA
    Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Update on paraneoplastic syndromes.
    Dropcho EJ
    Curr Opin Neurol; 2005 Jun; 18(3):331-6. PubMed ID: 15891421
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-Ri-associated paraneoplastic ophthalmoplegia-ataxia syndrome in a woman with breast cancer: a case report and review of the literature.
    Sena G; Gallo G; Vescio G; Gambardella D; de Franciscis S; Renne M
    J Med Case Rep; 2020 Jun; 14(1):67. PubMed ID: 32527295
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autoimmune and paraneoplastic neurological disorders: A review of relevant neuroimaging findings.
    Akkus S; Elkhooly M; Amatya S; Shrestha K; Sharma K; Kagzi Y; Khan E; Gupta R; Piquet AL; Jaiswal S; Wen S; Tapia M; Samant R; Sista SR; Sriwastava S
    J Neurol Sci; 2023 Nov; 454():120830. PubMed ID: 37856996
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antibodies to neural cell surface and synaptic proteins in paraneoplastic neurologic syndromes.
    Budhram A; Sechi E
    Handb Clin Neurol; 2024; 200():347-364. PubMed ID: 38494289
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
    Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
    Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Paraneoplastic Diseases of the Central Nervous System.
    Galli J; Greenlee J
    F1000Res; 2020; 9():. PubMed ID: 32194943
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Paraneoplastic neurological syndromes: a review.
    Toothaker TB; Rubin M
    Neurologist; 2009 Jan; 15(1):21-33. PubMed ID: 19131854
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Paraneoplastic autoimmune movement disorders.
    Lim TT
    Parkinsonism Relat Disord; 2017 Nov; 44():106-109. PubMed ID: 29097081
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Paraneoplastic movement disorders: phenomenology, diagnosis, and treatment.
    Chirra M; Marsili L; Gallerini S; Keeling EG; Marconi R; Colosimo C
    Eur J Intern Med; 2019 Sep; 67():14-23. PubMed ID: 31200996
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
    Chatterjee M; Hurley LC; Tainsky MA
    Gynecol Oncol Rep; 2017 Aug; 21():37-44. PubMed ID: 28653032
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical Spectrum, Therapeutic Outcomes and Prognostic predictors in Paraneoplastic Neurological Syndromes - Experiences from a Tertiary Care Center in India.
    Vijayaraghavan A; Alexander PT; Nair AV; Sivadasan A; Mani AM; Mathew D; Shaikh A; Benjamin RN; Prabhakar AT; Jude J; Mani S; Aaron S; Mathew V; Alexander M
    Ann Indian Acad Neurol; 2021; 24(1):32-39. PubMed ID: 33911377
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Paraneoplastic encephalitis: clinically based approach on diagnosis and management.
    Vaišvilas M; Ciano-Petersen NL; Macarena Villagrán-García MD; Muñiz-Castrillo S; Vogrig A; Honnorat J
    Postgrad Med J; 2023 Jun; 99(1173):669-678. PubMed ID: 37389581
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ovarian Teratoma-Related Paraneoplastic Neurological Syndromes.
    Lin J; Wang M; Wang J; Li J
    Front Oncol; 2022; 12():892539. PubMed ID: 35651803
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A pilot study on neurological manifestations and antibodies against antigens in children with hematological and other cancers.
    Polizzi A; Ruggieri M; Clover L; La Spina M; Pulvirenti A; Amyes E; Vincent A
    Eur J Paediatr Neurol; 2013 Jan; 17(1):97-101. PubMed ID: 22889753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.